Search results

ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.

The User Advisory Committee (UAC) are pleased to present this year's invited speakers.

ANSTO scientist, Dr Klaus Wilcken of the Centre for Accelerator Science, used cosmogenic nuclide dating to determine the ages of layered sand and gravel samples, in which seven footprints of the flightless bird, the moa, were found on the South Island in New Zealand in 2019.

You are invited to submit to the various awards from ANSTO and the User Meeting 2025 organising committee. 

In collaboration with the French National Institute of Health and Medical Research (INSERM) and the French International Space Agency (CNES), ANSTO scientists are undertaking research on the radiobiological effects of secondary particles that are created when radiation interacts with the shielding on the International Space Station.

About 70 representatives from business and industry groups, local business chambers, councils and the education sector from southern Sydney heard about ANSTO’s Innovation Precinct.

Industrial Engagement Manager at ANSTO and Professor in Advanced Structural Materials at the University of Sydney, Anna Paradowska is among the authors who contributed to a 2019 paper that was recently awarded the ASM International ASM Henry Marion Howe Medal in Metallurgical and Materials Transactions A.

A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.

This scholarship recognises outstanding ability and promise in the field of nuclear science and technology, specifically as it applies to nuclear energy. Successful applicants will demonstrate a history of interest in nuclear energy and a desire to continue this interest.

Neutron scattering instruments used by Japanese researchers.

This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.

Recent catastrophic Australian bushfires produced extremely high levels of fine particle pollution.

ANSTO shared plans for an Innovation Precinct in southern Sydney at a breakfast event.

A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.